Virtual Tumor Board: Sarcoma Disease-September 2020

Activity Overview

In this tumor board, participants will learn through case-based discussions about:

Recognizing the potential role of chemotherapy in the multimodality management of STS patients
Differentiating the pros and cons of neoadjuvant versus postoperative chemotherapy in the treatment of a primary STS
Identifying potential candidates for chemotherapy based upon level of metastatic risk, age, and comorbidities.
Summarizing common chemotherapy regimens used for STS neoadjuvant/adjuvant therapy (drugs, number of cycles)
Distinguishing variables (disease biology, patient factors) that determine the potential role of chemotherapy in the management of oligometastatic disease

Moderator is John Kane, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Panelists are:
Kenneth Cardona, MD, Emory University, Winship Cancer Institute, Atlanta, GA
Chee-Chee H. Stucky, MD, Mayo Clinic Arizona, Phoenix, AZ
Maria Alejandra Zarzour, MD, MD Anderson Cancer Center, Houston, TX

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered